Dailipharma
ActiveThe computed 12-month bankruptcy probability of Dailipharma is 1.7% (moderate). The 2025 annual accounts show equity of €74k and a net result of €3k. Equity is growing by ~15.8% per year across the filed fiscal years. Its solvency ranks better than 40% of 18237 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
45
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability43▼-14
Solvency47▼-6
Growth52=
Track record94
Bankruptcy probability, 12 months
1.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €3k at 30 days acceptable
Liquidity short (current ratio 0.54 against 1.87 in 2024; short-term debt: 44.2% and cash: 7.9% of total assets), and 77.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
22.3%
Return on assets
1%
Age of the figures
15 mo
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
2 d late
2024
4 d late
2023
1 d early
2022
on the day
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close22-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€74k▲ 4.6%
2024 · €71k
2022: €20k
2023: €67k
2024: €71k
2022 → 2025
Total assets
€334k▲ 31.5%
2024 · €254k
2022: €177k
2023: €235k
2024: €254k
2022 → 2025
Net result
€3k▼ 11.5%
2024 · €4k
2022: €15k
2023: €48k
2024: €4k
2022 → 2025
Working capital
€-68k
2024 · €67k
2022: €15k
2023: €59k
2024: €67k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€20k-€67k▲ 241%€71k▲ 5.5%€74k▲ 4.6%
Operating result€19k-€60k▲ 220%€7k▼ 88.0%€17k▲ 131%
Net result€15k-€48k▲ 223%€4k▼ 92.2%€3k▼ 11.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 131% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €334k
Fixed assets
€255k▲ 131%
Current assets
€80k▼ 44.8%
Equity and liabilities €334k
Equity
€74k▲ 4.6%
Debt
€260k▲ 41.9%
The debt ratio rises from 72.0% to 77.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€32k▲
2024 · €13k
Cash flow
€18k▲
2024 · €9k
Solvency
22.3%▼
2024 · 28.0%
Current ratio
0.54▼
2024 · 1.87
Quick ratio
0.44▼
2024 · 1.32
Debt / equity
3.49▲
2024 · 2.57
ROE
4.4%▼
2024 · 5.2%
ROA
1.0%▼
2024 · 1.5%
Interest coverage
2.72▼
2024 · 4.36
Debt
€260k▲
2024 · €183k
Debt ≤ 1 year
€148k▲
2024 · €77k
Debt > 1 year
€112k▲
2024 · €106k
Income taxes
€2k▲
2024 · €975
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€254k€334k▲
Fixed assets21/28€110k€255k▲
Intangible fixed assets21€85k€235k▲
Tangible fixed assets22/27€26k€20k▼
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€22k€17k▼
Current assets29/58€144k€80k▼
Amounts receivable after more than one year29€3k€3k=
Other amounts receivable291€3k€3k=
Stocks and contracts in progress3€42k€14k▼
Stocks30/36€42k€14k▼
Amounts receivable within one year40/41€30k€36k▲
Trade receivables40€23k€27k▲
Other amounts receivable41€7k€9k▲
Cash at bank and in hand54/58€69k€26k▼
Deferred charges and accrued income490/1€900€245▼
Equity and liabilities
Total equity and liabilities10/49€254k€334k▲
Equity10/15€71k€74k▲
Contributions10/11€5k€5k=
Reserves13€66k€69k▲
Distributable reserves133€66k€69k▲
Amounts payable17/49€183k€260k▲
Amounts payable after more than one year17€106k€112k▲
Financial debts170/4€106k€112k▲
Amounts payable within one year42/48€77k€148k▲
Current portion of amounts payable after more than one year42€8k€32k▲
Trade debts44€68k€113k▲
Suppliers440/4€68k€113k▲
Taxes, remuneration and social security45€981€2k▲
Taxes450/3€981€2k▲
Other amounts payable47/48€399€399=
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€15k▲
Other operating charges640/8€671€487▼
Gross operating margin9900€14k€32k▲
Operating profit (loss)9901€7k€17k▲
Financial income75/76B€506€12▼
Recurring financial income75€506€12▼
Financial charges65/66B€3k€12k▲
Recurring financial charges65€3k€12k▲
Profit (loss) for the period before taxes9903€5k€5k▲
Income taxes67/77€975€2k▲
Profit (loss) for the period9904€4k€3k▼
Profit (loss) for the period to be appropriated9905€4k€3k▼
Appropriation of the result
Profit (loss) to be appropriated9906€4k€3k▼
Transfer to equity691/2€4k€3k▼
To other reserves6921€4k€3k▼
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
State Gazette act
Capital & shares · Purpose · Statutes amendment · Resignations & appointmentsGeneral meeting · Share issue · Name change16 facts ▸
State Gazette act
Capital & shares · Purpose · Statutes amendment · Resignations & appointments
General meeting · Share issue · Name change16 facts ▸
- General meeting, 2021-08-03
- Share issue, 1:100, splitsing
- Share issue, B-Aandelen, 150000
- Share issue, ESOP Inschrijvingsrechten, 23684
- Name change, Dailipharma
- Purpose change, Het ontwikkelen, produceren, marketing, distribueren en verkopen van voedingssupplementen, functionele voeding en gezondheidsproducten...
- Statutes amendment
- Statutes amendment
- Accounting effect, 2026-12-31
- Capital
- Director appointment, Jan Helskens Consulting (bestuurder (Investeerder Bestuurder))
- Permanent representative, Jan HELKSENS
- +4 further facts in this act
02-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 2 days late
2025
30-06
Financial
Weakest financial yearnet €3k ▼11.5%
Net result drops to €3k, the lowest in the series.
04-02
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 4 days late
2024
30-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Highest result since 2022net €48k ▲223%
Operating result €60k, net result €48k, both a record.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 director, no change since 2021
Jan Helskens Consulting
CurrentBestuurder (investeerder bestuurder) · since 03-08-2021 · Private limited company · perm. rep.: Jan HELKSENS
03-08-2021
Appointed as Bestuurder (investeerder bestuurder)
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Doorniksestraat(Kor) 278500 KortrijkGround area
114 m²
Building footprint
114 m²
Volume, LiDAR
1,120 m³
Parcel 34353H0306/00_000, Flanders · tallest building 19.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
STERQ
since 20202.309.287.908
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34353H0306/00_000 | Flanders | 114 m² | 1 · 114 m² | 19.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2025 · 4 entries · 35,500 EUR awarded · 10,500 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 34,000 EUR | 9,000 EUR |
| 2024 | 1 | 0 EUR | 1,500 EUR |
| 2023 | 1 | 1,500 EUR | 0 EUR |
Schemes
Kmo-groeisubsidie: steun voor groeitrajecten bij kmo's (stopgezet)
Subsidies voor internationaal ondernemen
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteKortrijk2.309.287.908
Similar companies · same sector, comparable size
BRAVOURE
BE 0841.893.979
Anzegem · Eq €74k
WITTE RAVEN PROJECT
BE 0726.995.006
Sint-Niklaas · Eq €74k
FUNRA
BE 0824.837.916
Vorst · Eq €74k
Design District
BE 0640.999.061
Leuven · Eq €75k
E-Vape
BE 0744.574.176
Aarschot · Eq €75k
Of 4,245 companies in sector 47789 we hold annual accounts for 1,020. 801 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded08-10-2020
Fiscal year end30-06
Legal name NL
STERQ
Activities, NACEBEL
10890Manufacture of food products
47789Other retail sale of new goods
47540Retail sale of electrical household appliances
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:hello@dailipharma.com